MATE 2 Inhibitors
DBCAT003953Pharmacologic class
A DrugBank category of 58 drugs. 56 of them are approved.
- Part of
- MATE inhibitors
- Also known as
- Multidrug and toxin extrusion protein 2 Inhibitors
What you can answer from here — as of August 09, 2019
Which targets do MATE 2 Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account